VDRM MUCH HIGHER PART 2 (PHARMA ANALYSIS)
as noted above in my analysis which has been so kindly and appreciated to remain for the board to view at there leisure...
appreciate each market and research each company that presently controls each market PFE JNJ LLY MNKD BGEN AMGN and that VDRM is a pure play on licensing and patents which is brilliant in its own and is lead by people that understand this and appreciate so by controlling 75% of the outstanding stock here
lets break it down just a few sectors and make it a working model for all to add on to so the board is kept knowledge based for all
PFE Viagra is a category killer but it is a pill - and a pill is a introduction internally to the blood stream which out of fear a great portion of the population will just not take, now factor in a female Viagra alternative that is topical and replace the male Viagra with the same topical and its obvious that PFE will be forced to enter some sort of licensing agreement to hold onto there market share and as well look to capitalize on the female market as well ( m on f , and f on f ) there are those that will only use topical not internal
LLY and MNKD are the diabetic market and its huge - toenail fungal market - now add on a turnaround solution they have been needing for years, to treat at home foot infections ( home care largest market globally ) and that market alone is extraordinary with multiple companies all vying to be the dominant player and VDRM having the solution to license
JNJ marketplace is wounds - the band , now graduate it to the ability to speed the process up say 10 fold to heal any scrapes scratched wounds and to hold there market-share JNJ will be forced to enter some sort of licensing deal just to hold the line or risk crippling there empire quite easily
MRK and JNJ baldness market is in a level all itself, as its a do it yourself world we live in - add a just for men/ ladies crowd solution to expand into the baldness market and make that a CVS Walgreen's etc play for direct access more licensing
without even touching on the other markets there is exceptional growth here ( see my numbers post above that breaks the numbers down for all to see )
now lets sum it up with patent and licensing which is perfect, VDRM is already in the queue since 2014 to getting approved , have already done the 3-6-9-12 month studies with unreal results, and a new FDA will speed the process even faster come Jan 20th, also the MJ market CBDs will open up even more access, the population whole is more comfortable with topical that pills, and with VDRM technology all gets converted to topical from pills, so VDRM is the pure play licensing company to own...sales wise will be multiple billions 25b marketplace, and at 3 - 5x avg sales - the fundamentals are primed for a multi year movement...VDRM is a pure play on licensing....
PART 3 analysis will be upcoming soon - anyone that wishes to engage let me know and lets talk email or here
my suggestions are purely my own
Market Data 
Markets 
AI
